Overview
Yoshihiro Inamoto is a Hematologist Oncology provider in Seattle, Washington. Dr. Inamoto is rated as an Experienced provider by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Adult T-Cell Leukemia, Bone Marrow Transplant, and Bone Graft.
His clinical research consists of co-authoring 251 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chronic Myelomonocytic Leukemia (CMML).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Association Of University Physicians
Anna Halpern is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Halpern has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Chronic Myelomonocytic Leukemia (CMML), and Bone Marrow Aspiration. Dr. Halpern is currently accepting new patients.
The Association Of University Physicians
Maria Ghiuzeli is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Ghiuzeli is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). Her top areas of expertise are Myelodysplastic Syndrome (MDS), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Ghiuzeli is currently accepting new patients.
The Association Of University Physicians
Raya Mawad is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Mawad is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Philadelphia-Negative Chronic Myeloid Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Mawad is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Graft Versus Host Disease (cGvHD)
- Graft Versus Host Disease (GvHD)
- Distinguished
- Adult T-Cell LeukemiaDr. Inamoto isDistinguished. Learn about Adult T-Cell Leukemia.
- Bone Marrow TransplantDr. Inamoto isDistinguished. Learn about Bone Marrow Transplant.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Inamoto isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Dr. Inamoto isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaDr. Inamoto isAdvanced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Inamoto isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- AnemiaDr. Inamoto isExperienced. Learn about Anemia.
- Aplastic AnemiaDr. Inamoto isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Inamoto isExperienced. Learn about B-Cell Lymphoma.
- Bone GraftDr. Inamoto isExperienced. Learn about Bone Graft.
- Chronic B-Cell Leukemia (CBCL)Dr. Inamoto isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Inamoto isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).